(5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one

C104H116N24O8S2 — CID 159782866

IUPAC(5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
SMILESC[C@@H]1C(=O)N(C)Cc2c(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)nc(C3CCOCC3)n21.C[C@H]1C(=O)N(C)Cc2c(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)nc(C3CCOCC3)n21.Cc1ncc(-c2cc3ccc(C)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)[C@@H]5C)c3cn2)s1.Cc1ncc(-c2cc3ccc(C)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)[C@H]5C)c3cn2)s1
InChIInChI=1S/2C27H29N5O2S.2C25H29N7O2/c2*1-15-5-6-19-11-21(23-13-28-17(3)35-23)29-12-20(19)24(15)25-22-14-31(4)27(33)16(2)32(22)26(30-25)18-7-9-34-10-8-18;2*1-15-25(33)29(2)14-21-23(27-24(32(15)21)16-7-9-34-10-8-16)17-5-6-20-19(11-17)22(28-31(20)4)18-12-26-30(3)13-18/h2*5-6,11-13,16,18H,7-10,14H2,1-4H3;2*5-6,11-13,15-16H,7-10,14H2,1-4H3/t2*16-;2*15-/m1010/s1
InChIKeyNHOUNTMPZYQYJY-AQRWYNRTSA-N
MW1894.37 g/mol
LogP17.06
Rot. Bonds12

About (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one

(5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one (PubChem CID 159782866) has the molecular formula C104H116N24O8S2 and a molecular weight of 1894.37 g/mol. Its IUPAC name is (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one.

Molecular Properties

Compound Name(5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
PubChem CID159782866
Molecular FormulaC104H116N24O8S2
Molecular Weight1894.37 g/mol
Exact Mass1892.88
IUPAC Name(5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
SMILESC[C@@H]1C(=O)N(C)Cc2c(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)nc(C3CCOCC3)n21.C[C@H]1C(=O)N(C)Cc2c(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)nc(C3CCOCC3)n21.Cc1ncc(-c2cc3ccc(C)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)[C@@H]5C)c3cn2)s1.Cc1ncc(-c2cc3ccc(C)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)[C@H]5C)c3cn2)s1
InChIInChI=1S/2C27H29N5O2S.2C25H29N7O2/c2*1-15-5-6-19-11-21(23-13-28-17(3)35-23)29-12-20(19)24(15)25-22-14-31(4)27(33)16(2)32(22)26(30-25)18-7-9-34-10-8-18;2*1-15-25(33)29(2)14-21-23(27-24(32(15)21)16-7-9-34-10-8-16)17-5-6-20-19(11-17)22(28-31(20)4)18-12-26-30(3)13-18/h2*5-6,11-13,16,18H,7-10,14H2,1-4H3;2*5-6,11-13,15-16H,7-10,14H2,1-4H3/t2*16-;2*15-/m1010/s1
InChIKeyNHOUNTMPZYQYJY-AQRWYNRTSA-N
XLogP17.06
TPSA312.28 Ų
H-Bond Donors
H-Bond Acceptors30
Rotatable Bonds12
Heavy Atoms138
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001894.37
LogP ≤ 517.06
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1030

Analyze (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one?
The IUPAC name of (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one (CID 159782866) is (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one.
What is the SMILES notation for (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one?
The canonical SMILES for (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one is C[C@@H]1C(=O)N(C)Cc2c(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)nc(C3CCOCC3)n21.C[C@H]1C(=O)N(C)Cc2c(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)nc(C3CCOCC3)n21.Cc1ncc(-c2cc3ccc(C)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)[C@@H]5C)c3cn2)s1.Cc1ncc(-c2cc3ccc(C)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)[C@H]5C)c3cn2)s1.
What is the InChIKey of (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one?
The InChIKey is NHOUNTMPZYQYJY-AQRWYNRTSA-N. The full InChI is InChI=1S/2C27H29N5O2S.2C25H29N7O2/c2*1-15-5-6-19-11-21(23-13-28-17(3)35-23)29-12-20(19)24(15)25-22-14-31(4)27(33)16(2)32(22)26(30-25)18-7-9-34-10-8-18;2*1-15-25(33)29(2)14-21-23(27-24(32(15)21)16-7-9-34-10-8-16)17-5-6-20-19(11-17)22(28-31(20)4)18-12-26-30(3)13-18/h2*5-6,11-13,16,18H,7-10,14H2,1-4H3;2*5-6,11-13,15-16H,7-10,14H2,1-4H3/t2*16-;2*15-/m1010/s1.
What are the key properties of (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one?
(5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one has a molecular weight of 1894.37 g/mol, XLogP of 17.06, 12 rotatable bonds, 0 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5S)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;(5R)-5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one is sourced from PubChem (CID 159782866), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).